Onderneming IntelliPharmaCeutics International Inc. OTC Bulletin Board
Aandelen
CA4581733090
Farmaceutische producten
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Licensing
45,2
%
| - | - | 0 | 45,2 % | - |
Up-front Fees
29,0
%
| - | - | 0 | 29,0 % | - |
Other Services
25,8
%
| - | - | 0 | 25,8 % | - |
Verkoop per regio
CAD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
United States
45,2
%
| - | - | 0 | 45,2 % | - |
Canada
29,0
%
| 0 | nan % | 0 | 29,0 % | - |
Other
25,8
%
| - | - | 0 | 25,8 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Amina Odidi
FOU | Founder | - | 01-01-98 |
Isa Odidi
CEO | Chief Executive Officer | - | 01-01-98 |
Comptroller/Controller/Auditor | - | 01-04-07 | |
Corporate Officer/Principal | - | 01-02-14 | |
Patrick Yat
PRN | Corporate Officer/Principal | - | 01-01-92 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Norman Betts
BRD | Director/Board Member | 68 | 22-01-19 |
Isa Odidi
CEO | Chief Executive Officer | - | 01-01-98 |
Amina Odidi
FOU | Founder | - | 01-01-98 |
Bahadur Madhani
BRD | Director/Board Member | - | 01-03-06 |
Shawn Graham
BRD | Director/Board Member | - | 01-05-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 33 092 665 | 32 511 067 ( 98,24 %) | 0 | 98,24 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
GROWLIFE, INC. 10.84% | 3 662 761 | 10.84% | 7 326 $ |
Bedrijfsgegevens
Intellipharmaceutics International, Inc.
30 Worcester Road
M9W 5X2, Toronto
+416 798 3001
http://www.intellipharmaceutics.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,68% | 681 mld. | |
+19,14% | 556 mld. | |
-4,35% | 361 mld. | |
+17,65% | 325 mld. | |
+3,77% | 285 mld. | |
+13,66% | 235 mld. | |
+4,34% | 199 mld. | |
-11,98% | 189 mld. | |
-3,79% | 157 mld. |